12
Total investments
8
Early stage
2
Mid stage
0
Late stage
18y
Years active
Portfolio
12 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Seed Investor
Dec 2021
Formance enables Platforms and Fintech companies to build modern financial applications composing payments, banking, lending, investing, and insurance through complex fund flows.
Formance provides an agnostic infrastructure, allowing them to build and operate sophisticated fund flows with the financial service providers of their choice. Our open source and modular components ensure flexibility, ownership, and a shorter time-to-market.
The Formance Platform comes with four services: Ledger, Connectivity, Flows, and Reconciliation. Each service integrating seamlessly with one another, providing a scalable and extensible financial core system.
Board Observer
Sep 2021
Valink Therapeutics focusses on synergistic and non-obvious target combinations to create novel multivalent bispecific antibody-drug conjugates (bsADCs) that transform the treatment of solid tumors and other indications.
Valink is a platform therapeutics company focussing on the discovery of bsADCs based out of Cambridge, MA and London, UK. The company is a VC-backed & Y Combinator (W21)-incubated spin-out of the University of Oxford, with over $20M total capital raised.
Seed Investor
2021
Inoviv uses a novel technology platform based on targeted proteomics to support pharmaceutical companies with biomarker test development.
Investor
Feb 2020
We believe that talent should be recognised and valued for their contribution. At Wanted, we're committed to improve the job market transparency by empowering talents to be paid what they deserve.
* Sign-up in less than a minute.
* Stay completely anonymous.
* Receive job offers at a committed salary only.
Board Member
Sep 2019
Nomagic delivers AI powered robotic picking solutions that transform how warehouses operate. Our advanced vision systems and machine learning algorithms enable robots to handle millions of different items with speed and precision, helping e-commerce, retail and logistics leaders achieve new levels of efficiency, accuracy and scalability.
From piece-picking automation to seamless integration with warehouse management systems (WMS), Nomagic’s technology is designed to reduce operational costs, solve labour shortages and meet ever growing customer expectations.
We work with leading brands and fulfilment providers worldwide to optimise their order fulfilment, returns processing and inventory management, all while delivering a faster, more reliable supply chain.
Specialties: AI robotics, warehouse automation, robotic picking, computer vision, machine learning, fulfilment optimisation, e-commerce logistics, retail supply chain solutions.
Mission: To make warehouses smarter, more flexible and more sustainable through cutting-edge robotics and AI.
Board Observer
Mar 2019
Our mission is to help breast cancer patients live longer, better lives through earlier detection. We combine new deep learning methods, data science and radiology insights to help doctors find malignancies in mammograms. According to external clinical trial results, Kheiron’s deep learning technology achieves state-of-the-art malignancy detection support in breast cancer screening. European regulatory approval is expected shortly.
Board Observer
2015
Hello, we are eMed Healthcare UK.
We provide market-leading digital-first primary care service and chronic care management solutions; with high quality, accessible care for all.
eMed prioritises our members’ quality of care and experience through our digital-first 24/7 primary care service with quick and easy access to a range of specialists including GPs, nurses, pharmacists, physios and mental health practitioners.
We complete over 1.2 million appointments annually. Our services are tried and trusted - 4.8* rating in the app store and over 93% of consultations receiving a 5-star rating. And we operate the GP at Hand practice, the largest GP practice in the UK, on behalf of the NHS.
We have expanded our services focusing on chronic care management to empower people to proactively manage their own health across a wide range of chronic conditions, wherever they are.
Starting with our new clinician-led weight management programme, which supports members on their journey to help reach their goals; we are redefining what it means to provide digital-first care.
eMed Healthcare UK acquired Babylon Health in 2023. eMed Healthcare UK is redefining digital-first primary care and chronic care management, with a relentless focus on the quality of care and the user experience.
Investor
2014
Deliveroo is an award-winning delivery service founded in 2013 by William Shu and Greg Orlowski.
Deliveroo works with approximately 176,000 best-loved restaurants and grocery partners, as well as around 150,000 riders to provide the best food delivery experience in the world. Deliveroo is headquartered in London, with offices around the globe.
Deliveroo operates across 9 markets, including Belgium, France, Italy, Ireland, Qatar, Singapore, United Arab Emirates, Kuwait and the United Kingdom.
Board Member
2013
IMMUNIO secures your web applications against all attackers. It is the easiest, most effective method to ensure that you are alerted when important security events are triggered, and that threats are dealt proactively.
Security in 2 minutes.
Experience · 14 entries
All (14)
Investments (12)
Founder (1)
Board (6)
2023
2021
Seed Investor
Dec 2021
Formance enables Platforms and Fintech companies to build modern financial applications composing payments, banking, lending, investing, and insurance through complex fund flows.
Formance provides an agnostic infrastructure, allowing them to build and operate sophisticated fund flows with the financial service providers of their choice. Our open source and modular components ensure flexibility, ownership, and a shorter time-to-market.
The Formance Platform comes with four services: Ledger, Connectivity, Flows, and Reconciliation. Each service integrating seamlessly with one another, providing a scalable and extensible financial core system.
Board Observer
Sep 2021
Valink Therapeutics focusses on synergistic and non-obvious target combinations to create novel multivalent bispecific antibody-drug conjugates (bsADCs) that transform the treatment of solid tumors and other indications.
Valink is a platform therapeutics company focussing on the discovery of bsADCs based out of Cambridge, MA and London, UK. The company is a VC-backed & Y Combinator (W21)-incubated spin-out of the University of Oxford, with over $20M total capital raised.
Seed Investor
2021
Inoviv uses a novel technology platform based on targeted proteomics to support pharmaceutical companies with biomarker test development.
Show all 14 entries ↓
Investment activity
2008–2021 · 12 investments
Recent (last 2 years)Earlier
